It was reported that 23.98% of cancer inpatients in Changchun, China were IgG-positive and 2.25% IgM-positive, and that the IgG-positivity rates were significantly higher in case of nasopharyngeal carcinoma and rectal cancer than in other cancers (Yuan et al., 2007). The gene discussed is CD40LG; the disease is rectal cancer.